TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Double Bond Pharmaceutical International AB (publ)
Closing information (x1000 NOK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
1,388
|
1,176
|
932 |
Financial expenses |
3,953
|
0
|
1 |
Earnings before taxes |
-17,564
|
-14,340
|
-9,028 |
EBITDA |
-13,416
|
-14,158
|
-8,860 |
Total assets |
11,748
|
14,558
|
27,108 |
Current assets |
5,083
|
6,146
|
18,248 |
Current liabilities |
6,323
|
3,139
|
3,805 |
Equity capital |
5,425
|
11,418
|
23,303 |
- share capital |
4,830
|
2,992
|
2,696 |
Employees (average) |
10
![]() |
10
![]() |
10 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
46.2%
|
78.4%
|
86.0% |
Turnover per employee |
139
|
118
|
93 |
Profit as a percentage of turnover |
-1265.4%
|
-1219.4%
|
-968.7% |
Return on assets (ROA) |
-115.9%
|
-98.5%
|
-33.3% |
Current ratio |
80.4%
|
195.8%
|
479.6% |
Return on equity (ROE) |
-323.8%
|
-125.6%
|
-38.7% |
Change turnover |
129
|
271
|
-199 |
Change turnover % |
10%
|
30%
|
-18% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.